Temple University - Lewis Katz School of Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Temple University - Lewis Katz School of Medicine has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Chronic Liver Disease, Cirrhosis, Heart Failure.
Sponsors: Target PharmaSolutions, Inc., Bodyport Inc., Amgen.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Temple University - Lewis Katz School of Medicine has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Temple University - Lewis Katz School of Medicine has 3 clinical trials on record, with 1 currently active. Their work covers Chronic Liver Disease, Cirrhosis, Heart Failure.
Temple University - Lewis Katz School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.